Biotechnology
Arctic Vision announces exclusive licensing agreement with ActualEyes
To develop and commercialize cell therapy to potentially replace corneal endothelial keratoplasty inGreater China and South Korea * Arctic Vision to partner with ActualEyes to introduce novel approach of using cultured corneal endothelial cells to treat corneal endothelial dysfunction and pote...
Luye Life Sciences Unveils Cutting-edge Advances in Gene and Cell Therapy at ASGCT 2021
BOSTON, May 13, 2021 /PRNewswire/ -- The Boston R&D Center and GeneLeap Biotech, two subsidiaries of Luye Life Sciences Group, took part in the 24th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, presenting the progress of four of the company's latest preclinical developments in ...
An oral antiviral drug from Korea may be a problem solver for COVID-19
SEOUL, South Korea, May 13, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced that Dr.Jin-Ho Choi, a Chief Scientist of its major shareholding bio tech company CNPharm and Chair Professor at Dankook University, presented the study titled 'COVID-19 Game Changer Drug – a novel orga...
Pregene and Dr. Reddy's Announce License Agreement for Anti-BCMA CAR-T PRG1801 in India
BEIJING, May 13, 2021 /PRNewswire/ -- Beijing Time May 10, 2021 — Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) and Shenzhen Pregene Biopharma Co., Ltd. today announced an agreement whereby Dr Reddy's will acquire an exclusive license in the Republic ofInd...
Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive Dr. Jenny (Yajin) Ni as Chief Technology Officer
SUZHOU and SHANGHAI, China, May 10, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced the appoin...
PharmAbcine Announces Encouraging Non-clinical Data of PMC-403 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting
DAEJEON, South Korea, May 10, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company presented an e-poster featuring non-clinical data of PMC-403 at the Association for Resea...
Bionomics BNC210 Expansion into Social Anxiety Disorder
* Rapid oral absorption of BNC210 novel tablet formulation ideally suited for acute treatment of anxiety in patients with Social Anxiety Disorder * BNC210 Phase 2b PTSD trial on target for start in mid-2021 with U.S. CRO Premier Research selected and clinical site identification underway * P...
Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases
SHANGHAI, May 9, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised$60 million in its Series B fi...
Daewoong showed improved performance both sales and earnings in Q1
* OP. income exceeded 20 billion won due to successful export of Fexuprazan and sales recovery * Nabota(botulinum toxin) revenue soared after settlement, historical high performance in March * Turnaround in earnings just started and will continue to 2H SEOUL, South Korea, May 7, 2021 /PRNew...
HanAll Biopharma Reports First Quarter 2021 Financial Results
* Q1'21 sales of KRW 27.8 billion increased 26% compared to Q1'20 * Q1'21 operating profit of KRW 5.4 billion increased 80% compared to Q1'20 * Q1'21 operating margin of 19%, up from 14% in Q1'20 * Better-than-expected sales and operating profit are largely due to an increase of R&D revenue...
VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business Update
AUSTIN, Texas, May 6, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onWednesday May 12, at 8:00 a.m. Eastern time to discuss its financial and operating results for the first quarter of 2021, in addition to providing a bu...
Carmine Therapeutics appoints Don Haut as CEO
CAMBRIDGE, Mass., May 5, 2021 /PRNewswire/ -- Carmine Therapeutics, Inc., an emerging leader in gene therapy, today announced thatDon Haut, PhD has been appointedas its Chief Executive Officer, and member of the Board of Directors. Founded and incubated by EVX Ventures, Carmine is developing ne...
Clarity receives US FDA clearance of IND Application for its next-generation PSMA theranostic products
SYDNEY, May 4, 2021 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has received a response from the U.S. Food and Drug Administration (FDA) on its Investigational New Drug (IND) appl...
Revotek Deploys Its Bioink Technology to Research Institutes
CHENGDU, China, April 29, 2021 /PRNewswire/ -- Recently, Revotek Co., Ltd. ("Revotek"), a vertically integrated biotech company specialized in 3D bioprinting, and West China Hospital ofSichuan University, a leading research hospital inChina, have reached an agreement, in which the latter shall i...
Alterity Therapeutics Limited Appendix 4C - Q3 FY21 Quarterly Cash Flow Report
Highlights: * Michael J. Fox Foundation grants Alterity $US495K for Parkinson's disease research evaluation * Strengthening profile at investment, scientific and clinical conferences * Dr David Stamler appointed Chief Executive Officer * Cash balance as at 31 March 2021 of A$32.8M MELBOURN...
GenScript Launches Research-Grade Lentiviral Vector Packaging Service
PISCATAWAY, N.J., April 28, 2021 /PRNewswire/ -- GenScript®
Samsung Biologics Reports First Quarter 2021 Financial Results
* Q1'21 revenue of KRW 260.8 billion increased 26% compared to Q1'20. * Q1'21 operating profit of KRW 74.3 billion increased 19% compared to Q1'20. * Q1'21 operating margin held steady at 28%. * All manufacturing facilities remain fully operational, without any disruptions caused by the COV...
TCI Co., Ltd. becomes Asia's first biotechnology company whose climate ambitions are validated by SBTi
TAIPEI, April 27, 2021 /PRNewswire/ -- TCI Co., Ltd. (8436. TWO), the leading nutraceutical ODM company, announced onApril 22nd that it is finally, after six months of review, recognized by the Science Based Targets Initiative (SBTi) as "committed" to aligning its actions to reduce greenhouse ...
PharmAbcine to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting
DAEJEON, South Korea, April 26, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company will present an e-poster featuring non-clinical data of PMC-403 at the Association for ...
I-Mab Announces Positive Topline Phase 2 Results for Olamkicept in Ulcerative Colitis
SHANGHAI and GAITHERSBURG, Md., April 26, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced positive topline results from its regional multi-center...
Week's Top Stories
Most Reposted
Tonik raises US$12M Pre-Series C to scale capital-efficient lending in the Philippines
[Picked up by 318 media titles]
2025-12-04 10:15Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem
[Picked up by 311 media titles]
2025-12-04 16:00Klook takes the lead among international travelers booking paid tours and activities in Japan
[Picked up by 309 media titles]
2025-12-04 13:12HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 301 media titles]
2025-12-09 13:31World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 297 media titles]
2025-12-03 09:00